MedPath
NMPA Approval

Latanoprost and Timolol Maleate Eye Drops

国药准字H20253633

March 18, 2025

Drug Information

拉坦噻吗滴眼液

眼用制剂

2.5ml:拉坦前列素125μg和马来酸噻吗洛尔12.5mg(按C₁₃H₂₄N₄O₃S计)

化学药品

March 18, 2025

Company Information

Applicant Company

广州市南沙区珠江工业园美德三路1号自编A区5层501房

Manufacturing Company

广州市南沙区珠江工业园美德三路1号自编B栋5楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉坦噻吗滴眼液 - NMPA 批准文号 | MedPath